AwardedCzechiaGoodsCZK 19,673,000
Monoklonální protilátka - Daratumumab I.
- Published
- Published 3 December 2025
- Deadline
- Closed 8 January 2026
Overview
The Institut klinické a experimentální medicíny procured supplies of the monoclonal antibody daratumumab (Janssen-Cilag s.r.o.) for parenteral administration to treat patients in approved and off-label indications. The contract was awarded on 14 January 2026 for 11,009,098.6 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 19,673,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 3 December 2025
- Deadline
- Closed
Antineoplastic and immunomodulating agents
Award outcome
- Awarded value
- CZK 11,009,099
- Award date
- 14 January 2026
- Contract period
- — → 24 December 2029
- Janssen-Cilag s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 February 2026
Contract Notice
3 December 2025
Contracting authority
Institut klinické a experimentální medicíny
Procuring entityPraha, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.